NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc.

Company type	Public
Traded as	AMEX:  NBY Russell Microcap Index component
Founded	2000
Founder	Ron Najafi
Headquarters	United States
Key people	Mark Sieczkarek, M.B.A., CEO and Chairman of BOD John (“Jack”) McGovern, CFO Tom Paulson, M.B.A., Strategic Planning Lewis J. Stuart, M.B.A., Chief Commercial Officer (CCO) Glenn Moro, VP, Marketing Avenova Justin M. Hall, Esq, Senior Vice President, General Counsel Greg Miller, Director, Strategic Sales
Website	novabay.com

NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on products for eye care. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. ^[1] and NeutroPhase, used in treatment of Necrotizing Fasciitis ^{[2] [3]}

History

NovaBay Pharmaceuticals, Inc. was founded in 2000 by Ron Najafi to create a stable version of HOCl. ^{[4] [ citation needed ]} Najafi, chemistry Nobel laureate Herbert C. Brown, and Purdue University Professor Dale Margerum recruited Dr. Lu Wang to become NovaBay's Director of Product Development.^{[ citation needed ]} She developed the stable version of pure hypochlorous acid, without bleach impurities, which became NovaBay's first product, NeutroPhase. ^{[5] [6] [7] [8]}

NovaBay later launched additional products named CelleRx™ for Plastic Surgery and i-Lid™ Cleanser (Now Avenova) that was cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis. ^[9]

References

1. "NovaBay Avenova has a low toxicity but kills eyelid bacteria in dry eye or blepharitis patients".
2. "Treatment of Acute Necrotizing Fasciitis Using Negative Pressure Wound Therapy and Adjunctive NeutroPhase Irrigation Under the Foam". Wounds Research. Retrieved 2019-12-11.
3. "NNFF Names NovaBay's (NBY) NeutroPhase Its Official 'Flesh-Eating Disease' Wound Cleanser". StreetInsider.com. Retrieved 2019-12-11.
4. "Hypochlorous Acid as a Potential Wound Care Agent Part I" (PDF).
5. "510(k) Summary NeutroPhase® Skin and Wound Cleaner OTC" (PDF). Archived from the original (PDF) on October 4, 2013.
6. "Hypochlorous Acid as a Potential Wound Care Agent Part II" (PDF).
7. "NeutroPhase® in chronic non-healing wounds" (PDF).
8. "Treatment of Acute Necrotizing Fasciitis Using Negative Pressure Wound Therapy and Adjunctive NeutroPhase Irrigation Under the Foam".^{[ failed verification ]}
9. "NovaBay Avenova has a low toxicity but kills eyelid bacteria in dry eye or blepharitis patients".

External links

• Companies portal

• www.novabay.com